Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gambia ETVAX Efficacy Trial
PACTR202010819218562Phase 2Completed
- Sponsor
- Scandinavian Biopharma
- Start
- Jan 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in Enterotoxigenic Escherichia coli diarrhea and gastroenteritis comparing ETVAX with Placebo (2 arms). Started Jan 2021; status: completed.
02
Drugs
ETVAX
03
Conditions
Enterotoxigenic Escherichia coli diarrheagastroenteritis
Beyond the preview
Go deeper on PACTR202010819218562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202010819218562.